A phase II study of post-remission therapy with pembrolizumab in older patients with acute myeloid leukemia.
Quann K, Lontos K, Sehgal A, Raptis A, Im A, Redner RL, Dorritie KA, Agha M, Hou JZ, Farah R, Rossetti J, Normolle DP, Whiteside TL, Hsu YS, Boyiadzis M.
Quann K, et al. Among authors: raptis a.
Haematologica. 2024 Dec 1;109(12):4106-4111. doi: 10.3324/haematol.2024.285313.
Haematologica. 2024.
PMID: 39113675
Free PMC article.
No abstract available.